Skip to Main Content

Author Details

Joachim Weischenfeldt
University of Copenhagen
2004
50
27
PMIDPaper TitleJournal TitlePublished Year
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
37862305Hunting for the elusive target antigen in gestational alloimmune liver disease (GALD).PLoS One2023
37156210When 3D genome changes cause disease: the impact of structural variations in congenital disease and cancer.Curr Opin Genet Dev2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
37862305Hunting for the elusive target antigen in gestational alloimmune liver disease (GALD).PLoS One2023
37156210When 3D genome changes cause disease: the impact of structural variations in congenital disease and cancer.Curr Opin Genet Dev2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
34018316Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.Mol Oncol2022
36046215Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins.Hemasphere2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35764888Structural variations in cancer and the 3D genome.Nat Rev Cancer2022
36274067Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.Leukemia2022
36325372Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.Neurooncol Adv2022
34018316Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.Mol Oncol2022
35124694Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.Bone Marrow Transplant2022
35764888Structural variations in cancer and the 3D genome.Nat Rev Cancer2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
36046215Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins.Hemasphere2022
36274067Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.Leukemia2022
36325372Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.Neurooncol Adv2022
35124694Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.Bone Marrow Transplant2022
34151700Mutations known from B-cell lymphoid malignancies are not found in CD34<sup>+</sup> stem cells from patients with lymphoma.Leuk Lymphoma2021
34215580Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens.Sci Adv2021
34151700Mutations known from B-cell lymphoid malignancies are not found in CD34<sup>+</sup> stem cells from patients with lymphoma.Leuk Lymphoma2021
34663818TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.Nat Commun2021
34663818TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis.Nat Commun2021
34215580Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens.Sci Adv2021
32203146Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.Leukemia2020
32203146Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study.Leukemia2020
31697811Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality.Blood2020
32181815Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.Blood2020
32629384Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq).EBioMedicine2020
31697811Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality.Blood2020
32629384Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq).EBioMedicine2020
32181815Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.Blood2020
30833416Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistance.Cold Spring Harb Mol Case Stud2019
31615875Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability.J Cell Biol2019
31861273A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.Cancers (Basel)2019
30833416Response to olaparib in a <i>PALB2</i> germline mutated prostate cancer and genetic events associated with resistance.Cold Spring Harb Mol Case Stud2019
31861273A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy.Cancers (Basel)2019
31615875Regulation of ETAA1-mediated ATR activation couples DNA replication fidelity and genome stability.J Cell Biol2019
29535149SvABA: genome-wide detection of structural variants and indels by local assembly.Genome Res2018
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
29535149SvABA: genome-wide detection of structural variants and indels by local assembly.Genome Res2018
29489754The landscape of genomic alterations across childhood cancers.Nature2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
30537516Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.Cancer Cell2018
29753700Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.Lancet Oncol2018
29489754The landscape of genomic alterations across childhood cancers.Nature2018
  • 1 - 50 of 100

Recommended Authors

The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 32
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 22
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 22
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 6
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 8
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 15
McGill University
Career Start Year 2006
Number of shared co-authors 19
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 15
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 7
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 35
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 43
University of California
Career Start Year 2003
Number of shared co-authors 2
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 18
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 34
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 44
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 17
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 2
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 13
Early Cancer Institute, University of Cambridge
Career Start Year 1999
Number of shared co-authors 18
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 8
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 7
The Broad Institute of Harvard and MIT
Career Start Year 1998
Number of shared co-authors 21
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 32
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 21
The Ohio State University
Career Start Year 1988
Number of shared co-authors 28
University of British Columbia
Career Start Year 1988
Number of shared co-authors 28

Collaborators

European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 23
Charite - University Hospital Berlin
Co-authored papers 13
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 12
German Cancer Research Center (DKFZ)
Co-authored papers 10
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 9
Universita del Piemonte Orientale
Co-authored papers 8
Berlin Institute of Health (BIH) and Charite
Co-authored papers 8
St. Anna Children's Cancer Research Institute (CCRI)
Co-authored papers 8
University of California san francisco
Co-authored papers 8
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 7
St Jude Children's Research Hospital
Co-authored papers 7
German Cancer Research Center (DKFZ)
Co-authored papers 6
German Cancer Research Center (DKFZ)
Co-authored papers 6
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 6
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 6
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Co-authored papers 6
German Cancer Research Center (DKFZ)
Co-authored papers 5
Co-authored papers 5
German Cancer Research Center
Co-authored papers 5
National Center for Tumor Diseases (NCT) Heidelberg
Co-authored papers 5
Co-authored papers 5
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 5
University of Heidelberg
Co-authored papers 5
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 5
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 5
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Rigshospitalet, University of Copenhagen
Co-authored papers 4
Max Planck Institute for Molecular Genetics
Co-authored papers 4
University of Augsburg
Co-authored papers 4
Max-Planck-Institute for Molecular Genetics
Co-authored papers 4